China Shineway Pharmaceutical Group Limited (CSWYF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.51 Billion | 588.09 Million | 498.18 Million | 384.86 Million | 393.79 Million | 388.82 Million |
| Cost of Revenue | 158.13 Million | 150.69 Million | 125.67 Million | 96.78 Million | 105.42 Million | 105.01 Million |
| Gross Profit | 4.35 Billion | 437.39 Million | 372.5 Million | 288.08 Million | 288.37 Million | 283.81 Million |
| Operating Expenses | 341.51 Million | 331.17 Million | 289.92 Million | 226.86 Million | 219.61 Million | 208.77 Million |
| Selling, General and Administrative Expenses | 325.95 Million | 313.69 Million | 272.5 Million | 212.41 Million | 204.66 Million | 189.39 Million |
| Research and Development Expenses | 110.46 Million | 17.48 Million | 17.41 Million | 14.44 Million | 14.94 Million | 19.38 Million |
| Other Expenses | - | 104.98 Million | 82.85 Million | 86.16 Million | - | - |
| Cost and Expenses | 499.65 Million | 481.86 Million | 415.59 Million | 323.65 Million | 325.04 Million | 313.79 Million |
| Operating Income | 975.53 Million | 106.22 Million | 82.58 Million | 61.21 Million | 68.75 Million | 75.03 Million |
| Interest Expense | 2.73 Million | 93.78 Thousand | 193.79 Thousand | 2.4 Million | 386.81 Thousand | - |
| Income Tax Expense | 38.3 Million | 28.91 Million | 25.25 Million | 14.49 Million | 20.31 Million | 24.69 Million |
| Earnings before Tax | 175.46 Million | 136.5 Million | 111.28 Million | 57.24 Million | 93.54 Million | 101.22 Million |
| Net Income | 137.15 Million | 107.59 Million | 86.03 Million | 42.75 Million | 73.22 Million | 76.53 Million |
| Earnings Per Share Basic | 0.18 | 0.14 | 0.11 | 0.06 | 0.09 | 0.09 |
| Earnings Per Share Diluted | 0.18 | 0.14 | 0.11 | 0.06 | 0.09 | 0.09 |
| Weighted Average Shares Outstanding | 755.4 Million | 755.4 Million | 755.14 Million | 756.74 Million | 780.81 Million | 816.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 755.4 Million | 755.4 Million | 755.14 Million | 756.74 Million | 780.94 Million | 817.86 Million |
| Gross Margin | 0.96 | 0.74 | 0.75 | 0.75 | 0.73 | 0.73 |
| EBIT Margin | 0.03 | 0.20 | 0.19 | 0.18 | 0.19 | 0.21 |
| Profit Margin | 0.03 | 0.18 | 0.17 | 0.11 | 0.19 | 0.20 |
| EBITDA | 145.76 Million | 114.95 Million | 121.31 Million | 68.33 Million | 76.51 Million | 107.41 Million |
| Earnings Before Tax Margin | 0.22 | 0.18 | 0.17 | 0.16 | 0.17 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 143.56 Million | 144.49 Million | 292.93 Million | 638.96 Million | 145.03 Million | 346.07 Million |
| Cost of Revenue | 35.39 Million | 35.62 Million | 72.98 Million | 158.79 Million | 36.13 Million | 85.8 Million |
| Gross Profit | 108.16 Million | 108.86 Million | 219.94 Million | 480.17 Million | 108.9 Million | 260.26 Million |
| Operating Expenses | 69.59 Million | 70.05 Million | 166.81 Million | 342.93 Million | 73.1 Million | 175.72 Million |
| Selling, General and Administrative Expenses | 66.52 Million | 66.95 Million | 158.2 Million | - | 78.33 Million | 168.76 Million |
| Research and Development Expenses | 3.07 Million | 3.09 Million | 8.61 Million | - | 4.26 Million | 6.95 Million |
| Other Expenses | - | - | - | 167.38 Million | - | - |
| Cost and Expenses | 104.99 Million | 105.67 Million | 239.8 Million | 501.72 Million | 109.24 Million | 261.52 Million |
| Operating Income | 38.56 Million | 38.81 Million | 53.12 Million | 137.24 Million | 26.3 Million | 84.54 Million |
| Interest Expense | 395.67 Thousand | - | 354.91 Thousand | 2.73 Million | - | 24.67 Thousand |
| Income Tax Expense | 16.2 Million | 16.31 Million | 12.57 Million | 38.3 Million | 6.22 Million | 25.94 Million |
| Earnings before Tax | 59.31 Million | 59.69 Million | 78.69 Million | 175.46 Million | 38.96 Million | 96.85 Million |
| Net Income | 43.1 Million | 43.38 Million | 66.12 Million | 137.15 Million | 32.73 Million | 70.9 Million |
| Earnings Per Share Basic | 0.06 | 0.06 | 0.09 | - | 0.04 | 0.09 |
| Earnings Per Share Diluted | 0.06 | 0.06 | 0.09 | - | 0.04 | 0.09 |
| Weighted Average Shares Outstanding | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million | 758.8 Million | 755.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million |
| Gross Margin | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
| EBIT Margin | 0.31 | 0.31 | 0.22 | - | 0.22 | 0.28 |
| Profit Margin | 0.30 | 0.30 | 0.23 | 0.21 | 0.23 | 0.20 |
| EBITDA | 44.11 Million | 44.4 Million | 65.71 Million | - | 31.76 Million | 96.96 Million |
| Earnings Before Tax Margin | 0.27 | 0.27 | 0.18 | 0.21 | 0.18 | 0.24 |
600869
AMST
SPQDF
API
BCNAY
300652